Overview
Multi-Center Study of Different Doses Domperidone in Feeding Intolerance
Status:
Completed
Completed
Trial end date:
2017-06-01
2017-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this clinical multi-center study is to determine whether different doses of domperidone are effective in the treatment of feeding intolerance in premature infantPhase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Nanfang Hospital of Southern Medical UniversityCollaborators:
Guangdong Provincial Maternal and Child Health Hospital
Guangzhou Panyu Central Hospital
Maternal and Child Health Hospital of Foshan
Maternal and Child Health Hospital,Huadu District
Shen-Zhen City Maternity and Child Healthcare HospitalTreatments:
Domperidone
Criteria
Inclusion Criteria:- the residual milk and glucose over 55%
- abdominal distention or vomiting;
- Reduce,delay or disruption of enteral feeding
Exclusion Criteria:
- Four weeks before the start of this study had participated in other clinical trials
- pulmonary hypertension;
- Infants with necrotizing enterocolitis
- Gastrointestinal tract malformation, congenital heart disease
- Pre-existing QT extend/between long QT syndrome;
- ascites
- Have been used or will use drugs suppress CYP3A4
- Other risk factors for prolong the QT